Alcohol Consumption Guidelines for Patients on Clopidogrel and Apixaban
General Alcohol Recommendations
- The European Society of Cardiology recommends that men limit alcohol consumption to less than 14 units per week and women to less than 8 units per week, with the safest approach being one drink per session with interspersed abstinent days, to minimize health risks 1
- The optimal approach is to drink less than these upper limits, with complete abstinence providing the best health outcomes, according to the European Society of Cardiology guidelines 1
- Most standard drinks contain 8-14g of alcohol per drink, so these limits translate to roughly 1-2 drinks per day maximum for men and less than 1 drink per day for women, as recommended by the European Society of Cardiology 1
Specific Considerations for Antiplatelet/Anticoagulant Therapy
- Minimizing cumulative bleeding risk can be achieved by limiting alcohol consumption to one drink per session with interspersed abstinent days, as recommended by the European Society of Cardiology and supported by Praxis Medical Insights 2
- Avoiding regular daily consumption can help prevent blood pressure elevation, as recommended by the European Society of Cardiology 1
Critical Situations Requiring Complete Abstinence
- Patients should completely abstain from alcohol in situations such as active bleeding, recent major bleeding event, planned surgical procedures, concurrent use of NSAIDs, liver disease, or impaired hepatic function, as recommended by the American College of Cardiology and supported by the Journal of the American College of Cardiology and Circulation 2, 3, 4
- The European Society of Cardiology recommends complete abstinence from alcohol in patients with liver disease or impaired hepatic function 1
Alcohol Consumption Guidelines with Clopidogrel and Apixaban
Critical Situations and Bleeding Risk
- The American Heart Association, as published in Circulation, recommends complete abstinence from alcohol in patients with active bleeding, recent major bleeding event, planned surgical or invasive procedures, concurrent use of NSAIDs, liver disease, or recent gastrointestinal bleeding, due to increased bleeding risk when taking clopidogrel and apixaban together 5
- Patients with multiple risk factors for GI bleeding, including advanced age, concurrent anticoagulant use, and alcohol consumption, face compounding risks, as noted in research published in Circulation 5
- The combination of clopidogrel and apixaban increases the bleeding risk, with alcohol adding to this risk through multiple mechanisms, including interference with platelet function and increased likelihood of gastrointestinal bleeding, as reported in Circulation 5
- Monitoring for signs of bleeding, such as unusual bruising, blood in stool/urine, and prolonged bleeding from cuts, is crucial when consuming alcohol while taking clopidogrel and apixaban, according to guidelines published in Circulation 5